Efficacy and safety of baricitinib in treatment of systemic lupus erythematosus: a systematic review and meta-analysis

  • Published on 11/17/2023
  •  Reading time: 4 min.

Allam Abdallah R. , Alhateem Mohamed Salah , Mahmoud Abdelrahman Mohamed

https://ror.org/05sjrb944 Faculty of Medicine Menoufia University Yassin Abdelghaffar Street from Gamal Abdelnaser Street. Shebin Al- Kom 32511 Menoufia Egypt


Background SLE is an autoimmune disease marked by broad immunological dysregulation and multi-system inflammation. Baricitinib is one of the novel treatments for SLE. We conducted this meta-analysis to evaluate its safety and effectiveness in treating SLE.
Method We looked for all published randomized controlled trials in PubMed, Scopus, Web of Science, and Cochrane and included all RCTs comparing baricitinib and placebo in the treatment of SLE. Review...


To continue reading this article in Full-Text...

* Access is totally free, without commitment or condition. Service exclusively reserved for healthcare professionals.

Peer-Reviewed Journals A-Z

Search | Advanced search

Get the latest news in Rheumatology

Receive our newsletter to stay up to date with the latest news in Rheumatology